Homepage

FUNDING ADVISORY
September 25, 2008


Dear Colleagues:

As part of the New York University School of Medicine's commitment to research
excellence and translational medicine, we are pleased to announce a call for
proposals for the Applied Research Support Fund.

The purpose of the Fund is to encourage and promote the development of
research projects and technologies that have the near-term potential for
licensing and commercialization.

To be considered for this round, please submit a one page preliminary
proposal to the Office of Industrial Liaison (OIL) by October 24, 2008.

Applicants may request up to a maximum budget of $75,000 in direct costs.
Funding is ordinarily for one year and is non-renewable.

For detailed guidelines and an application, or if you have any questions,
please visit the OIL web site at: http://www.med.nyu.edu/OIL or call the
Office at x3-8178.

About Technology Transfer at NYU
The NYU School of Medicine has one of the most successful track records of
commercializing technology of any academic medical center, with over 24
products based on NYU technology having been brought to market to benefit
patients. These include the drugs Remicade and Sutent, as well as numerous
medical devices and diagnostics. In addition, 15 products are currently in
clinical trials by licensees, including drugs for cancers, heart disease,
Alzheimer's Disease, Parkinson's Disease, malaria, addiction, and wound
healing. The annual number of new inventions generated by faculty has more
than doubled since 2000, and the number of new license agreements signed
with companies each year has more than tripled. Revenues generated from
technology commercialization are shared with the inventors under the NYU
Patent Policy, which is one of the most generous in the country, and the
remainder is devoted to supporting the research and clinical activities of
the Medical Center.

The Office of Industrial Liaison, part of the NYU Office of Science and
Research, is responsible for managing all activities relating to the
protection and commercial promotion of inventions made at New York
University, as well as research collaborations with industry.

Faculty, staff, and students whose research or clinical activities may lead
to new discoveries or products are encouraged to contact the Office of
Industrial Liaison as early as possible, to discuss their work. Under
patent laws, patent applications must be filed prior to any publication or
presentation of the invention to avoid loss of rights. By contacting the
Office early, patent protection can be sought if appropriate, without delays
in publishing and presenting new results.

For more information, contact the NYU Office of Industrial Liaison at
212-263-8178 or visit http://www.med.nyu.edu/OIL

Sincerely,

Vivian Lee
Senior Vice President, Vice Dean for
Science & Chief Scientific Office

Abram M. Goldfinger
Executive Director,
Industrial Liaison/Technology Transfer

Homepage